Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,776 across all filing types
Latest filing 2021-09-01 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
金宇生物技术股份有限公司第十届董事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from the company 金宇生物技术股份有限公司. It details the approval of a restricted stock incentive plan and the granting of reserved restricted stocks to incentive recipients. The document includes voting results and mentions compliance with company law and articles of association. It does not contain financial statements or detailed financial performance data. It is an announcement of a board decision related to management and governance matters, specifically about stock incentives. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report or a regulatory filing about financial results or audit.
2021-09-01 Chinese
金宇生物技术股份有限公司独立董事关于公司2021年半年度募集资金存放与实际使用情况的独立意见
Regulatory Filings
2021-08-26 Chinese
金宇生物技术股份有限公司第十届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from a company's 10th board's 11th meeting. It states that the board reviewed and approved the company's 2021 half-year report and a special report on the use of raised funds. The document is short (716 characters) and does not contain the actual half-year financial report or detailed financial data, but rather announces the approval of these reports. It also references that the detailed special report is disclosed on the stock exchange website. Therefore, this document is an announcement of board resolutions and approvals, not the full interim report itself. According to the filing definitions and the 'menu vs meal' rule, this fits best under Board/Management Information (MANG) as it announces board meeting decisions and approvals.
2021-08-26 Chinese
金宇生物技术股份有限公司2021年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2021 半年度报告摘要' which translates to '2021 Half-Year Report Summary'. It contains financial data for the half-year period, including total assets, net profit, earnings per share, and shareholder information. The document explicitly states it is a summary of the half-year report and advises investors to read the full half-year report on the official website. The length is 2429 characters, which is relatively short and appears to be a summary rather than a full report. However, it contains substantive financial data and analysis for the half-year period, not just an announcement or a link to a report. According to the definitions, a half-year or quarterly report with actual financial statements and analysis is classified as an Interim / Quarterly Report (IR). The document is not a mere announcement or certification, so it should not be classified as RPA or RNS. Therefore, the correct classification is IR with high confidence. H1 2021
2021-08-26 Chinese
金宇生物技术股份有限公司第十届监事会第十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding the review and approval of the company's 2021 half-year report and a special report on the use of raised funds. It includes statements about compliance with laws and regulations, and voting results. The document is short (956 characters) and primarily announces the approval of the half-year report rather than containing the report itself. It does not contain detailed financial statements or substantive financial data. Therefore, it is not an Interim/Quarterly Report (IR) but rather an announcement related to governance and supervisory board decisions. Given the nature of the content, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure.
2021-08-26 Chinese
金宇生物技术股份有限公司2021年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2021年半年度募集资金存放与实际使用情况的专项报告" which translates to "2021 Half-Year Special Report on the Deposit and Actual Use of Raised Funds." It details the management, usage, and storage of funds raised through a non-public stock issuance, including specific amounts, dates, regulatory references, and compliance with Chinese securities regulations. The document is a specialized report focused on the use of capital raised by the company, not a general financial report or earnings release. It is not an announcement of a report publication but the report itself, given the detailed financial figures and compliance information. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length (5095 characters) supports it being a substantive report rather than a brief announcement.
2021-08-26 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.